Botulinum Toxin for Benign Essential Blepharospasm, Hemifacial Spasm and Age-Related Lower Eyelid Entropion
- 1 February 1987
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 14 (1) , 42-45
- https://doi.org/10.1017/s0317167100026159
Abstract
Purified botulinum A exotoxin was used in the treatment of forty seven patients with benign essential blepharospasm, 11 patients with hemifacial spasm and 2 patients with age-related entropion. The treatment was effective in all three groups for an average of 3-4 months when symptoms recurred and repeated chemodenervation with toxin was needed. The commonest complication was transient ptosis with an overall frequency of 7.8%. This incidence increased to 11.1% with toxin doses higher than 25 units per orbicularis. The treatment was well accepted by the patients, who were subsequently able to return to pre-blepharospasm lifestyles.This publication has 7 references indexed in Scilit:
- A Pilot Study on the Use of Botulinum Toxin in Spasmodic TorticollisCanadian Journal of Neurological Sciences, 1985
- Botulinum A Toxin Injection as a Treatment for BlepharospasmArchives of Ophthalmology (1950), 1985
- Treatment of Essential BlepharospasmArchives of Ophthalmology (1950), 1984
- Blepharospasm SurgeryArchives of Ophthalmology (1950), 1981
- Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus SurgeryOphthalmology, 1980
- Surgical Correction of Intractable BlepharospasmAmerican Journal of Ophthalmology, 1965
- Relief of Intractable Blepharospasm*American Journal of Ophthalmology, 1951